Global Computer-aided Drug Discovery Market Anticipated to Garner $7,504.7 Million, Growing with 11.48% CAGR in the 2022–2030 Timeframe [240-Pages] | Details by Research Dive
16 mars 2023 09h00 HE
|
Research Dive
New York, USA, March 16, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global computer-aided drug discovery market. According to the report, the global market is projected...
Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies
08 mars 2023 11h20 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Muscular Dystrophy Association Announces Recipient of 2023 MDA Legacy Award for Achievement in Clinical Research is Merit Cudkowicz, MD, MSC, Renowned Neurologist and Clinical Researcher in ALS
06 mars 2023 09h00 HE
|
Muscular Dystrophy Association
New York, NY, March 06, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Merit Cudkowicz, MD, MSC, a renowned neurologist and clinical researcher in ALS (amyotrophic...
Alzheimer’s disease Diagnostics and Therapeutics Market to Surpass US$ 9,503.1 Million by 2030, Says Coherent Market Insights (CMI)
06 mars 2023 08h40 HE
|
CMI
Burlingame, March 06, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global Alzheimer’s disease diagnostics and therapeutics market is estimated to be valued at US$ 6,231.1...
Athira Pharma to Present Data Supporting Therapeutic Potential of Enhancing HGF/MET Neurotrophic System at Upcoming Scientific Conferences
06 mars 2023 07h00 HE
|
Athira Pharma, Inc.
BOTHELL, Wash., March 06, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
Brain Monitoring Market is Expected to Reach $8.0 billion | MarketsandMarkets.
28 févr. 2023 07h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The future of the brain monitoring industry is expected to be very exciting. With the rapid advancements in technology and the growth of artificial...
AB Science annonce la publication de l’étude clinique pivot de phase 3 avec le masitinib dans la maladie d’Alzheimer dans la revue Alzheimer's Research & Therapy
28 févr. 2023 02h03 HE
|
AB Science
COMMUNIQUE DE PRESSE PUBLICATION DE L'ETUDE CLINIQUE PIVOT DE PHASE 3 AVEC LE MASITINIB DANS LA MALADIE D'ALZHEIMER DANS LA REVUE ALZHEIMER'S RESEARCH & THERAPY Paris, 28 février 2023, 8h AB...
AB Science announced the publication of the masitinib pivotal phase 3 clinical trial in Alzheimer’s Disease in the journal Alzheimer's Research & Therapy
28 févr. 2023 02h03 HE
|
AB Science
PRESS RELEASE PUBLICATION OF THE MASITINIB PIVOTAL PHASE 3 CLINICAL TRIAL IN ALZHEIMER'S DISEASE IN THE JOURNAL ALZHEIMER'S RESEARCH & THERAPY Paris, 28 February, 2023, 8am CET ...
Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day
22 févr. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
Spotlight On Raising Awareness for Rare Diseases on February 28, 2023 Celebrating the Tireless Contributions of Patients and Advocates who Work with the Biotech Industry to Bring New Treatments to...
Alterity Therapeutics Receives Regulatory Authorization in France and Austria to Proceed with ATH434 Phase 2 Clinical Trial
16 févr. 2023 16h44 HE
|
ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...